Delivery Order SPE2DB20D3505-SPE2DB25FU9V2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply) with a ceiling value of $2,271.36. This firm fixed-price delivery order, issued on September 8, 2025, is expected to be completed by September 29, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120 count) on August 12, 2025, with a ceiling value of $2,271.36. This firm fixed-price delivery order is scheduled for completion by September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of YONSA 125 mg tablets (120 count). This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, is to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation and represents a child contract under AmerisourceBergen's larger federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120 count) valued at $9,085.44 under a firm fixed-price contract type. The award was made on September 24, 2025, with an ultimate completion date of October 16, 2025, and was competitively awarded with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,542.74 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply). The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of YONSA 125 mg tablets (120-count units). This firm fixed-price delivery order, with an ultimate completion date of September 25, 2025, represents a non-set-aside procurement under open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply). This is a firm fixed-price, non-set-aside delivery order issued on November 4, 2025, with an ultimate completion date of November 26, 2025. YONSA is a prescription medication used in oncology treatment, and the order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $17,563.84 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565098308 - YONSA 125 MG TABLET 120S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This is a firm fixed-price delivery order with an ultimate completion date of June 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of YONSA 125 mg tablets (120-count units) with a ceiling value of $2,271.36. This is a firm fixed-price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FU9V2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count units) valued at $2,271.36 under a firm fixed price contract type. This non-competitive delivery order, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and no set-aside designation was applied to this award. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal procurement portfolio demonstrates its critical role as a major pharmaceutical distributor serving military and veteran healthcare systems, with contract awards consistently reflecting competitively awarded delivery orders covering diverse pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/14/25 |